SINGAPORE, 04 May 2017 – NeoAsia (S) Pte Ltd, a regional distributor of skincare, medical aesthetic equipment and medical device products today has established the partnership with Syneron Candela, focusing on Vbeam® Perfecta, the Gold Standard Pulsed Dye Laser and Profound, the 1st Device to create all 3 skin fundamentals profoundly - elastin, collagen, hyaluronic acid. The machine delivers the radiofrequency energy through an array of needles into the dermal layer of skin to induce fractional damage for the purpose of collagen generation. It is scientifically proven to deliver energy directly to the deep dermis to stimulate neo-elastogenesis, neocollagenesis and hyaluronic acid deposition. Now Profound delivers fractional RF energy to the subcutaneous layer enabling treatment of adipose tissue and the septae as well. Profound is a comprehensive treatment addressing both the Dermal & SubQ layers. Confidently expand physicians offerings with this single treatment procedure with a 100% response* rate.
About Syneron Candela
Syneron Candela is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.
The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
Being the key player in AHA/PHA skincare technology, NeoAsia has been harnessing the challenges and opportunities of the business to make it all happen. Since its inception in 1995, NeoAsia has been dedicated to engaging sales, marketing and distribution of skincare, medical aesthetic equipment and medical device products to the medical community and consumers. NeoAsia's corporate headquarter is situated in Singapore, with its distribution networks extended to Malaysia, Brunei, Indonesia, Vietnam, Cambodia and China.